Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
What factors would push you to consider using IMRT vs opposed lateral fields for a T2N0 glottic SCC?
Would having supraglottic extension lead you to use IMRT?
Answer from: Radiation Oncologist at Academic Institution
I use IMRT for all. IMRT should not cause recurrence if done correctly.
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
A low lying larynx where parallel opposed lateral fields and anterior oblique fields are not feasible.
Sign in or Register to read more
2585
2579
Related Questions
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
How would you manage a presumed radiation induced sarcoma of the head and neck?
How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
What is the role of adjuvant RT for metastatic RCC to the thyroid resected with high-risk features?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?